Remarkably, the comparison of AP‐1 complex inhibition in the two co‐culture regions revealed a significantly reduced survival rate of CLL cells exposed to SR/T5 alone or in combination with Enzastaurin in the core region. The gene discussed is JUN; the disease is B-cell chronic lymphocytic leukemia.